|1.||Ehling-Schulz, Monika: 3 articles (03/2009 - 01/2005)|
|2.||Scherer, Siegfried: 3 articles (03/2009 - 01/2005)|
|3.||Bookchin, Robert M: 2 articles (05/2007 - 05/2006)|
|4.||Etzion, Zipora: 2 articles (05/2007 - 05/2006)|
|5.||Shen, Rui: 1 article (09/2015)|
|6.||Xue, Fei: 1 article (09/2015)|
|7.||Chen, Xianzhen: 1 article (09/2015)|
|8.||An, Ran: 1 article (04/2014)|
|9.||Nolte, David D: 1 article (04/2014)|
|10.||Robinson, J Paul: 1 article (04/2014)|
|1.||Myocardial Ischemia (Ischemic Heart Diseases)
02/01/1989 - "[The effect of valinomycin and nigericin on the efficacy of bacteriophage infection of staphylococcal cells]."
02/01/1989 - "The combined use of valinomycin and nigerimycin produces the maximum inhibition of phage infection (64.5%) at the stage of the introduction of DNA into the bacterial cell, which is indicative of a definite role played by the membrane potential and the pH gradient in the transport of phage DNA into staphylococcal cells."
02/01/1989 - "The effect of ionophore antibiotics, valinomycin and nigericin, on the generation of the membrane potential, the pH gradient and the efficacy of phage infection in tetracycline-resistant staphylococci has been studied. "
03/27/2001 - "Combination of concanamycin A, a vacuolar proton-ATPase inhibitor, and valinomycin, an ionophore that promotes K(+) efflux from cells, powerfully prevented poliovirus infection. "
04/01/2006 - "The GRPs-inhibitory action of valinomycin severe hypoglycemic and results in selective cell death of the stressed cancer cells. "
10/01/1997 - "Thus, the effects of valinomycin on tumor cells were examined. "
09/01/1975 - "It was found with the help of electron microscopy that valinomycin administered to mice with Ehrlich ascitic tumors in a dose inhibiting the proliferating activity induced impairements in the mitochondria. "
09/01/1975 - "A change in the ultrastructure of the tumor cells under the influence of valinomycin]."
08/01/1975 - "It was shown that repeated administrations of valinomycin in doses of 1.0 and 0.01 gamma/gm to mice with Ehrlich ascitic tumors inhibited the ascite development. "
|4.||Ehrlich Tumor Carcinoma
09/01/1975 - "[Action of valinomycin in vivo on Ehrlich ascites tumor cells. "
08/01/1975 - "[In vivo action of valinomycin on Ehrlich ascites tumor cells. "
06/30/1970 - "Effect of valinomycin on mitochondrial ultrastructure and function of intact Ehrlich ascites tumor cells."
08/20/1968 - "Valinomycin-stimulated glycolysis in Ehrlich ascites tumor cells."
01/01/1975 - "The membrane potential of Ehrlich ascites tumor cells and the effects of valinomycin and ouabain upon it have been determined. "
|5.||Dehydration (Water Stress)
10/15/2002 - "Recent studies have identified older, low-density sickle red blood cells (SSRBCs) that were resistant to dehydration by valinomycin, a K(+) ionophore. "
05/01/2007 - "When K(+) permeabilization was induced with valinomycin, the oldest and densest cells, which started nearest to the set density boundary, crossed it first, reflecting conservation of the normal age-density distribution pattern during dehydration. "
05/01/2006 - "Exposure of red blood cells (RBC) to the K+ -ionophore valinomycin (val), causes loss of KCl and water, resulting in cell dehydration, manifested by increased cell density. "
03/15/1996 - "We describe a 'profile migration' method in which dilute red cell suspensions in low-K+ media were permeabilized to K+ with a high concentration of valinomycin, rendering PCl the main rate-limiting factor for cell dehydration. "
01/01/1991 - "We have measured the viscoelastic properties of individual human HbAA red cells after graded dehydration induced by incubation with valinomycin at different external K levels. "
|4.||Anti-Bacterial Agents (Antibiotics)
|8.||DNA (Deoxyribonucleic Acid)
|4.||Drug Therapy (Chemotherapy)